Speaker illustration

Miss Su Jen Chua

Adelaide, South Australia (Australia)

Galectin 3 is markedly elevated in severe heart failure and predicts improvement in LV volumes post cardiac resynchronisation therapy

Event: ESC Congress 2016

Topic: Heart failure, other

Session: Prognostication in heart failure

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb